Today: 23 December 2025
Subscribe
Browse Category

Analyst Forecasts News 22 December 2025 - 23 December 2025

Applied Materials (AMAT) Stock After Hours Today (Dec. 22, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

Applied Materials (AMAT) Stock After Hours Today (Dec. 22, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

Applied Materials, Inc. (NASDAQ: AMAT) finished Monday’s session on a strong note—and then stayed relatively steady after the closing bell—heading into a holiday-shortened week where lighter liquidity and a busy U.S. data calendar could amplify moves in semiconductor stocks. AMAT
23 December 2025
 ·  ·  ·  · 
Broadcom (AVGO) Stock After Hours Today (Dec. 22, 2025): Latest Moves, Today’s Headlines, Analyst Forecasts, and What to Watch Before Tomorrow’s Open

Broadcom (AVGO) Stock After Hours Today (Dec. 22, 2025): Latest Moves, Today’s Headlines, Analyst Forecasts, and What to Watch Before Tomorrow’s Open

Broadcom Inc. (NASDAQ: AVGO) ended Monday’s session modestly higher and stayed steady in after-hours trading as investors head into a holiday-shortened week—and a packed U.S. economic-data Tuesday that could move rates, tech sentiment, and semiconductor leaders before the opening bell.
22 December 2025
 ·  ·  ·  ·  · 
Boeing Stock News Today (Dec. 22, 2025): BA Price Action, Fresh Headlines, Analyst Forecasts, and the 2026 Outlook

Boeing Stock News Today (Dec. 22, 2025): BA Price Action, Fresh Headlines, Analyst Forecasts, and the 2026 Outlook

Boeing Company (The) (NYSE: BA) is back in the spotlight on Monday, December 22, 2025, as investors balance encouraging signals on production discipline and supplier quality with persistent regulatory and headline risk. BA stock was last trading around $216.39, up
22 December 2025
 ·  ·  ·  ·  · 
Insmed (INSM) Stock News Today: Nasdaq‑100 Addition, Brensocatib Setback, and Updated Analyst Forecasts (Dec. 22, 2025)

Insmed (INSM) Stock News Today: Nasdaq‑100 Addition, Brensocatib Setback, and Updated Analyst Forecasts (Dec. 22, 2025)

Insmed Incorporated (NASDAQ: INSM) is ending 2025 with two headlines pulling the stock in opposite directions: fresh visibility from joining the Nasdaq‑100 Index and fresh volatility after a clinical disappointment for a key expansion effort. As of Monday, December 22,
22 December 2025
 ·  ·  ·  · 
ServiceNow (NOW) Stock News, Forecasts and Analyst Outlook for Dec. 22, 2025: Armis Deal Chatter, Stock Split Fallout, and What Investors Watch Next

ServiceNow (NOW) Stock News, Forecasts and Analyst Outlook for Dec. 22, 2025: Armis Deal Chatter, Stock Split Fallout, and What Investors Watch Next

Dec. 22, 2025 — ServiceNow (NYSE: NOW) is starting the holiday-shortened week in the spotlight for a very specific reason: investors are trying to price the company’s AI-and-security expansion strategy at the same time the stock is absorbing a 5-for-1
22 December 2025
 ·  ·  ·  ·  · 
IREN Limited Stock (NASDAQ: IREN) News Today: Why Shares Are Moving on Dec. 22, 2025, Plus Analyst Forecasts and Key Catalysts

IREN Limited Stock (NASDAQ: IREN) News Today: Why Shares Are Moving on Dec. 22, 2025, Plus Analyst Forecasts and Key Catalysts

IREN Limited (NASDAQ: IREN) is back in the spotlight on Monday, December 22, 2025, as the stock extends a whiplash month for investors who’ve watched it swing from euphoric AI optimism to financing-driven volatility and back again. In pre-market trading,
22 December 2025
 ·  ·  ·  ·  · 
Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Dec. 22, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) has abruptly shifted from a “rare-disease growth story” into a deal-driven stock, after BioMarin Pharmaceutical announced an all-cash agreement to acquire Amicus for $14.50 per share. With shares trading around $14.18
22 December 2025
 ·  ·  ·  ·  ·  · 
1 2 3 … 32
Go toTop